Drug Topics

JULY 1, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Community Pharmacies 315

Community Pharmacies Health and Personal Care Stores Independent Pharmacies Specialty Pharmacies 315

Drug Topics

JUNE 20, 2025

link] Recent Videos Related Content FDA Approves Dupilumab for Treatment of Bullous Pemphigoid Ashley Gallagher June 20th 2025 Article Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits. Jefferson Health. Accessed June 20, 2025.

Vaccines 449

Vaccines Independent Pharmacies Immunization Specialty Pharmacies 449

Drug Topics

JUNE 23, 2025

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes Ashley Gallagher June 19th 2025 Article The drug could also reduce chronic kidney disease when combined with insulin therapy.

Compounding 307

Compounding Specialty Pharmacies Independent Pharmacies Immunization 307

Drug Topics

JUNE 13, 2025

Low Sodium DASH Diet May Reduce Blood Pressure in Patients With T2D Killian Meara June 10th 2025 Article A modified DASH diet with lower sodium optimized for patients with type 2 diabetes reduced both systolic and diastolic blood pressure.

Compounding 242

Compounding Specialty Pharmacies Independent Pharmacies Immunization 242

Drug Topics

JUNE 11, 2025

Not only is it important for pharmacies and their employees to have protocols for natural disasters, but pharmacies should also educate their patients on properly storing and managing their medications during a state of emergency. Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote.

Health and Personal Care Stores 315

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Communication 315

Drug Topics

JUNE 20, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Vaccines 315

Vaccines Immunization Specialty Pharmacies Compounding 315

Pharmacy Times

JUNE 26, 2025

Explore the latest FDA-approved novel drugs transforming treatment options for various conditions, enhancing patient care and outcomes in community and specialty pharmacy.

Specialty Pharmacies 81

Specialty Pharmacies Patient Care FDA 81

Drug Topics

JUNE 6, 2025

HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema Ashley Gallagher May 30th 2025 Article The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.

Compounding 315

Compounding Specialty Pharmacies Independent Pharmacies Immunization 315

pharmaphorum

JULY 29, 2021

It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA approval will be specialty medications. Navigating the cost of specialty medications.

Specialty Pharmacies 111

Specialty Pharmacies FDA 111

Drug Topics

JUNE 10, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Community Pharmacies 247

Community Pharmacies Independent Pharmacies Patient Care Specialty Pharmacies 247

Drug Topics

JUNE 18, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Independent Pharmacies 247

Independent Pharmacies Community Pharmacies Immunization Specialty Pharmacies 247

Drug Topics

JUNE 18, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Communication 377

Communication Specialty Pharmacies Compounding Independent Pharmacies 377

Drug Topics

JUNE 6, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Vaccines 341

Vaccines Immunization Compounding Specialty Pharmacies 341

Drug Topics

JUNE 9, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Community Pharmacies 247

Community Pharmacies Immunization Specialty Pharmacies Compounding 247

Drug Topics

JUNE 5, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Health and Personal Care Stores 247

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Specialty Pharmacies 247

Drug Topics

JULY 2, 2025

3,4 Since then, several other formulations have received FDA approval, leading to research developments of multiple GLP-1s for treating people with overweight or obesity. image credit: photoopus / stock.adobe.com The first GLP-1RA approved for use in the US was exenatide (Byetta) in 2005 for patients with type 2 diabetes (T2D).

Compounding 247

Compounding Patient Care Specialty Pharmacies FDA 247

Drug Topics

JUNE 11, 2025

READ MORE: FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body The current treatment guidelines for patients with psoriasis include a variety of pharmacological options, such as biologics, phototherapy, and topicals.

Immunization 315

Immunization Documentation Specialty Pharmacies Compounding 315

Drug Topics

JUNE 25, 2025

Procedure Shows Promise for Sustained Weight Loss After GLP-1 Therapy Ashley Gallagher June 25th 2025 Article Revita is a procedure that modifies duodenal dysfunction and restores metabolic health, according to Fractyl Health. $0

Compounding 315

Compounding Insurance Coverage Insurance Specialty Pharmacies 315

Drug Topics

JULY 1, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Health and Personal Care Stores 247

Health and Personal Care Stores Independent Pharmacies Patient Care Specialty Pharmacies 247

Drug Topics

JUNE 12, 2025

Statins Have No Additional Antidepressive Effects as Add-On Treatment Ashley Gallagher June 5th 2025 Article Investigators found that simvastatin added to escitalopram for patients with obesity and major depressive disorder did not have increased antidepressive effects.

Compounding 281

Compounding Specialty Pharmacies Independent Pharmacies Immunization 281

Drug Topics

JULY 2, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Patient Care 247

Patient Care Specialty Pharmacies Compounding Independent Pharmacies 247

Drug Topics

JUNE 11, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Specialty Pharmacies 315

Specialty Pharmacies Compounding Independent Pharmacies Communication 315

Drug Topics

JUNE 17, 2025

Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes Ashley Gallagher June 13th 2025 Article For women in rural populations, access to education and care is limited, causing disparities in diabetes care.

Compounding 190

Compounding Specialty Pharmacies Independent Pharmacies Immunization 190

Drug Topics

JUNE 13, 2025

FDA Approves Roflumilast Foam For Plaque Psoriasis of Scalp, Body Ashley Gallagher May 22nd 2025 Article The supplemental new drug application for roflumilast (Zoryve) is approved for adult and pediatric patients 12 years and older.

Specialty Pharmacies 281

Specialty Pharmacies Compounding Independent Pharmacies Immunization 281

Drug Topics

JUNE 12, 2025

Risk of Adverse Pregnancy Outcomes Increases With Hepatitis B, Gestational Diabetes Ashley Gallagher June 9th 2025 Article Hepatitis B and liver functions have been found to be independent risk factors for gestational diabetes and are found to have the highest prevalence of abnormalities.

Compounding 247

Compounding Specialty Pharmacies Independent Pharmacies Immunization 247

Drug Topics

JULY 2, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Vaccines 247

Vaccines Immunization Compounding Communication 247

The Checkup by Singlecare

JULY 9, 2024

Dupixent (dupilumab) is an injectable prescription medication that’s approved by the Food and Drug Administration (FDA) to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps , prurigo nodularis, and eosinophilic esophagitis (EoE). “As What are specialty pharmacies? But there are some differences, too.

Specialty Pharmacies 52

Specialty Pharmacies Mail-Order Pharmacies Insurance Customer Service 52

Drug Topics

JUNE 20, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Community Pharmacies 281

Community Pharmacies CPhT Compounding Specialty Pharmacies 281

Hospital Pharmacy Europe

MARCH 6, 2023

Following the FDA approval, the company has created the Reata Education, Access, and Care Helpline ( REACH ), an integrated specialty pharmacy and patient services program, designed to help eligible patients access prescribed Reata medicines.

FDA 97

FDA Specialty Pharmacies Labelling Hospitals 97

Drug Topics

JUNE 17, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Specialty Pharmacies 216

Specialty Pharmacies Compounding Independent Pharmacies Immunization 216

Pharmaceutical Commerce

MAY 7, 2025

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring across the industry, prompting greater reliance on specialty pharmacy services and outsourced support.

Specialty Pharmacies 52

Specialty Pharmacies FDA 52

Drug Topics

JUNE 13, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy (..)

Specialty Pharmacies 190

Specialty Pharmacies Compounding Independent Pharmacies Immunization 190

PharmExec

MAY 7, 2025

Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring across the industry, prompting greater reliance on specialty pharmacy services and outsourced support.

Specialty Pharmacies 52

Specialty Pharmacies FDA 52

Pharmacy Times

JUNE 20, 2025

2019.04.011 Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. J Natl Med Assoc. 2019;111(5):540-545. doi:10.1016/j.jnma.2019.04.011 Subscribe Now!

Vaccines 73

Vaccines Compounding Pharmacies Immunization Hospitals 73

The Checkup by Singlecare

JUNE 5, 2025

Mounjaro (tirzepatide) is a brand-name prescription medication that’s approved by the Food and Drug Administration (FDA) to lower blood sugar levels in people with Type 2 diabetes. However, tirzepatide, the active ingredient in Mounjaro, is an FDA-approved weight loss medication under the brand name Zepbound. mL of 5 mg/0.5

Insurance 52

Insurance Compounding Documentation FDA 52

pharmaphorum

AUGUST 10, 2020

Roche is hoping to undercut hugely expensive rivals after the FDA approved its oral spinal muscular atrophy (SMA) drug Evrysdi (risdiplam). The FDA approved Evrysdi for the treatment of spinal muscular atrophy (SMA) in adults and children two months of age and older.

FDA 59

FDA Specialty Pharmacies 59

The Checkup by Singlecare

JUNE 5, 2025

Zepbound (tirzepatide) is a once-weekly injectable GIP/glucagon-like peptide-1 (GLP-1) receptor agonist that’s been approved by the Food and Drug Administration (FDA) to promote weight loss in adults with obesity or who are overweight with a weight-related health condition. It was later approved to treat sleep apnea in adults with obesity.

Insurance 52

Insurance Customer Service Compounding Documentation 52